Herbalife Ltd. Announces Record Second Quarter 2012 and Raises 2012 Earnings Guidance

  • Second quarter volume points of 1.2 billion increased 23 percent with increases in each of its six regions compared to the prior year period.
  • Second quarter EPS of $1.10 increased 25 percent compared to the prior year period EPS.
  • Raising FY’12 EPS guidance to a range of $3.88 to $3.98.
  • Board of directors approved a $0.30 per share quarterly dividend.
  • Board of directors approved a new $1 billion share repurchase authorization.
  • Company announces a $500 million increase in its credit facility.

LOS ANGELES--()--Herbalife Ltd. (NYSE: HLF) today reported second quarter record net sales of $1.0 billion, a 17 percent increase, driven by a 23 percent increase in volume points compared to the prior year period. The company reported net income of $133.4 million, or $1.10 per diluted share, compared to the second quarter 2011 net income of $111.2 million, or $0.88 per diluted share, reflecting an increase of 20 percent and 25 percent, respectively.

“The broad strength of our business success continued throughout the second quarter with strong sales performance from each of our six regions, along with record earnings and strong cash flow,” said Michael O. Johnson, the company’s chairman and CEO. “We believe the underlying drivers of our current business success, engaged distributors focused on globalizing daily consumption sales methods and products which are relevant for today’s global macro trends of obesity and an aging population, will continue to provide the catalyst for future growth.”

For the quarter ended June 30, 2012, the company generated cash flow from operations of $137.1 million, paid dividends of $35.1 million, invested $15.0 million in capital expenditures and repurchased $239.0 million in common shares outstanding under our share repurchase program. As of July 27, 2012 the company has completed the $427.9 million repurchase agreement announced on May 3, 2012. The company repurchased a total of 9.2 million shares at an average price of $46.37.

Second Quarter Regional Key Metrics1,2

Regional Volume Point and Average Active Sales Leader Metrics

          Volume Points (Mil)         Average Active Sales Leaders
Region           2Q'12         Yr/Yr % Chg         2Q'12         Yr/Yr % Chg
North America 305.0         18 % 65,828         18 %
Asia Pacific 313.8 29 % 61,329 35 %
EMEA 154.5 13 % 42,972 14 %
Mexico 203.9 17 % 55,969 21 %
South & Central America 167.2 30 % 41,966 27 %
China           57.7         54 %         11,949         43 %
Worldwide Total           1,202.1         23 %         269,974         24 %
 

Updated 2012 Guidance

Guidance for fully diluted 2012 EPS is based on the average daily exchange rates of the first two weeks of July 2012.

Based on current business trends the company’s third quarter fiscal 2012 and fiscal 2012 guidance is provided below.

          Three Months Ending           Twelve Months Ending
September 30, 2012 December 31, 2012
Low         High Low         High
Volume Point Growth vs 2011 13.0 % 15.0 % 17.0 % 19.0 %
Net Sales Growth vs 2011 10.0 % 12.0 % 15.0 % 17.0 %
Diluted EPS $ 0.97 $ 1.01 $ 3.88 $ 3.98
Cap Ex ($ millions) $ 35.0 $ 45.0 $ 110.0 $ 120.0
Effective Tax Rate 23.0 % 25.0 % 26.5 % 28.5 %
 

Announces Quarterly Dividend

The company reported today that its board of directors has approved a dividend of $0.30 per share to shareholders of record on August 14, 2012, payable on August 30, 2012.

Share Repurchase Program Update

Following the completion of the prior $1 billion share repurchase authorization, the company’s Board of Directors authorized a new $1 billion share repurchase authorization available to be utilized over the next 5 year period, expiring on June 30, 2017.

John DeSimone, the company’s chief financial officer, said, “This additional authorization speaks to our Board’s and management’s confidence in the company’s business’ fundamentals, financial results and on-going earnings power. The company intends to continue to utilize a meaningful portion of our excess free cash flow to return value to investors.” Since 2007, the company has returned $1.5 billion to shareholders through the repurchase of approximately 52.6 million shares and $350 million in dividends for a total of approximately $1.9 billion, or 118% of net income.

Herbalife’s future share repurchases, if any, may take place from time to time at management’s discretion based on market conditions, and shares may be purchased in open-market, privately negotiated or other transactions.

Announces a New $500 million Term Note Added to its Credit Facility

The company amended its credit facility to add a new $500 million term loan to the existing $700 million senior credit facility entered into in March 2011. This new facility was arranged by Bank of America Merrill Lynch with RaboBank, HSBC and Wells Fargo as joint lead arrangers and joint book managers.

Chief financial officer John DeSimone stated, “we believe that this new credit facility is yet another reflection of the financial strength of the company and will provide additional flexibility as we look to continue to increase shareholder value.”

Second Quarter Earnings Conference Call

Herbalife senior management will host an investor conference call to discuss its recent financial results and provide an update on current business trends on Tuesday, July 31, 2012 at 8 a.m. PST (11 a.m. EST).

The dial-in number for this conference call for domestic callers is (877) 317-1296 and (706) 634-5671 for international callers (conference ID 96426914). Live audio of the conference call will be simultaneously webcast in the investor relations section of the company's website at http://ir.herbalife.com.

An audio replay will be available following the completion of the conference call in MP3 format or by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers (conference ID 96426914). The webcast of the teleconference will be archived and available on Herbalife's website.

About Herbalife Ltd.

Herbalife Ltd. (NYSE:HLF) is a global nutrition company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 83 countries to and through a network of independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife's website contains information about Herbalife, including financial and other information for investors at http://ir.Herbalife.com. The company encourages investors to visit its website from time to time, as information is updated and new information is posted.

FORWARD-LOOKING STATEMENTS

This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words “may,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” and any other similar words.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:

  • any collateral impact resulting from the ongoing worldwide financial “crisis,” including the availability of liquidity to us, our customers and our suppliers or the willingness of our customers to purchase products in a difficult economic environment;
  • our relationship with, and our ability to influence the actions of, our distributors;
  • improper action by our employees or distributors in violation of applicable law;
  • adverse publicity associated with our products or network marketing organization;
  • changing consumer preferences and demands;
  • our reliance upon, or the loss or departure of any member of, our senior management team which could negatively impact our distributor relations and operating results;
  • the competitive nature of our business;
  • regulatory matters governing our products, including potential governmental or regulatory actions concerning the safety or efficacy of our products and network marketing program, including the direct selling market in which we operate;
  • legal challenges to our network marketing program;
  • risks associated with operating internationally and the effect of economic factors, including foreign exchange, inflation, disruptions or conflicts with our third party importers, pricing and currency devaluation risks, especially in countries such as Venezuela;
  • uncertainties relating to the application of transfer pricing, duties, value added taxes, and other tax regulations, and changes thereto;
  • uncertainties relating to interpretation and enforcement of legislation in China governing direct selling;
  • our inability to obtain the necessary licenses to expand our direct selling business in China;
  • adverse changes in the Chinese economy, Chinese legal system or Chinese governmental policies;
  • our dependence on increased penetration of existing markets;
  • contractual limitations on our ability to expand our business;
  • our reliance on our information technology infrastructure and outside manufacturers;
  • the sufficiency of trademarks and other intellectual property rights;
  • product concentration;
  • changes in tax laws, treaties or regulations, or their interpretation;
  • taxation relating to our distributors;
  • product liability claims; and
  • whether we will purchase any of our shares in the open markets or otherwise.

We do not undertake any obligation to update or release any revisions to any forward-looking statements or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

1 Supplemental tables that include additional business metrics can be found at http://www.ir.herbalife.com.

2 Worldwide Average Active Sales Leaders may not equal the sum of the Average Active Sales Leaders in each region due to the calculation being an average of Sales Leaders active in a period, not a summation, and the fact that some sales leaders are active in more than one region but are counted only once in the worldwide amount.

RESULTS OF OPERATIONS:

Herbalife Ltd.
Condensed Consolidated Statements of Income
(In thousands, except per share amounts)
(Unaudited)
                                       
Three Months Ended Six Months Ended
  6/30/2012   6/30/2011   6/30/2012   6/30/2011
 
North America $ 224,661 $ 185,159 $ 435,372 $ 352,159
Mexico 119,449 113,882 236,558 217,759
South and Central America 152,583 130,130 318,054 255,407
EMEA 161,635 162,017 315,627 315,954
Asia Pacific 296,548 237,103 556,496 436,406
China   77,072   51,363   134,016   97,065
Worldwide net sales 1,031,948 879,654 1,996,123 1,674,750
Cost of Sales   203,737   171,023   399,881   333,816
Gross Profit 828,211 708,631 1,596,242 1,340,934
Royalty Overrides 335,195 289,232 652,728 553,609
SGA   306,310   266,225   602,703   510,751
Operating Income 186,706 153,174 340,811 276,574
Interest Expense - net   3,169   855   4,542   3,503
Income before income taxes 183,537 152,319 336,269 273,071
Income Taxes   50,169   41,139   94,739   73,872
Net Income   133,368   111,180   241,530   199,199
 
Basic Shares 116,557 119,007 116,376 118,609
Diluted Shares 121,482 126,617 122,182 126,610
 
Basic EPS $ 1.14 $ 0.93 $ 2.08 $ 1.68
Diluted EPS $ 1.10 $ 0.88 $ 1.98 $ 1.57
 
Dividends declared per share $ 0.30 $ 0.20 $ 0.60 $ 0.33
 

Herbalife Ltd.
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
          Jun 30,             Dec 31,
  2012     2011  
 
ASSETS
Current Assets:
Cash & cash equivalents $ 286,166 $ 258,775
Receivables, net 108,633 89,660
Inventories 262,386 247,696
Prepaid expenses and other current assets 131,919 117,073
Deferred income taxes   56,998     55,615  
Total Current Assets 846,102 768,819
 
Property, plant and equipment, net 196,787 193,703
Deferred compensation plan assets 23,119 20,511
Deferred financing cost, net 4,222 4,797
Other assets 43,644 41,125
Marketing related intangibles and other intangible assets, net 311,428 311,764
Goodwill   105,490     105,490  
Total Assets $ 1,530,792   $ 1,446,209  
 
 
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable $ 79,031 $ 57,095
Royalty overrides 206,079 197,756
Accrued compensation 71,131 76,435
Accrued expenses 156,672 152,744
Current portion of long term debt 763 1,542
Advance sales deposits 36,298 31,702
Income taxes payable   16,356     31,415  
Total Current Liabilities 566,330 548,689
 
Non-current liabilities
Long-term debt, net of current portion 555,051 202,079
Deferred compensation plan liability 27,118 23,702
Deferred income taxes 72,828 72,348
Other non-current liabilities   38,746     39,203  
Total Liabilities 1,260,073 886,021
 
Commitments and Contingencies
 
Shareholders' equity:
Common shares 112 116
Additional paid in capital 288,050 291,950
Accumulated other comprehensive loss (42,927 ) (37,809 )
Retained earnings   25,484     305,931  
Total Shareholders' Equity   270,719     560,188  
   
Total Liabilities and Shareholders' Equity $ 1,530,792   $ 1,446,209  
 

Herbalife Ltd.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
         
Six Months Ended
  6/30/2012                 6/30/2011  
CASH FLOWS FROM OPERATING ACTIVITIES
Net income $ 241,530 $ 199,199
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization 36,613 36,657
Excess tax benefits from share-based payment arrangements (27,212 ) (19,544 )
Share based compensation expenses 12,497 11,103
Amortization of discount and deferred financing costs 572 435
Deferred income taxes (4,896 ) 671
Unrealized foreign exchange transaction loss (gain) (4,909 ) 5,452
Write-off of deferred financing costs - 914
Other 120 899
Changes in operating assets and liabilities:
Receivables (21,317 ) (26,966 )
Inventories (14,476 ) (26,489 )
Prepaid expenses and other current assets (9,367 ) (6,391 )
Other assets (3,124 ) (4,977 )
Accounts payable 22,948 19,411
Royalty overrides 7,932 16,873
Accrued expenses and accrued compensation (3,516 ) (2,995 )
Advance sales deposits 5,199 26,323
Income taxes 15,433 16,427
Deferred compensation plan liability   3,416     3,645  
NET CASH PROVIDED BY OPERATING ACTIVITIES   257,443     250,647  
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment (39,719 ) (44,428 )
Proceeds from sale of property, plant and equipment 43 190
Deferred compensation plan assets   (2,609 )   (2,055 )
NET CASH USED IN INVESTING ACTIVITIES   (42,285 )   (46,293 )
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends paid (70,310 ) (38,689 )
Borrowings from long-term debt 806,560 390,700
Principal payments on long-term debt (454,371 ) (408,329 )
Deferred financing costs - (5,729 )
Share repurchases (505,636 ) (115,287 )
Excess tax benefits from share-based payment arrangements 27,212 19,544
Proceeds from exercise of stock options and sale of stock under
employee stock purchase plan   10,356     8,280  
NET CASH USED IN FINANCING ACTIVITIES   (186,189 )   (149,510 )
EFFECT OF EXCHANGE RATE CHANGES ON CASH   (1,578 )   9,073  
NET CHANGE IN CASH AND CASH EQUIVALENTS 27,391 63,917
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD   258,775     190,550  
CASH AND CASH EQUIVALENTS, END OF PERIOD   286,166     254,467  
CASH PAID DURING THE YEAR
Interest paid $ 5,884   $ 4,062  
Income taxes paid $ 86,214   $ 49,738  
 

SUPPLEMENTAL INFORMATION

SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

(unaudited), (Dollars in Thousand, Except Per Share Data)

In addition to its reported results, the Company has included in the tables below adjusted results that the Securities and Exchange Commission defines as “non-GAAP financial measures.” Management believes that such non-GAAP financial measures, when read in conjunction with the Company’s reported results, can provide useful supplemental information for investors in analyzing period to period comparisons of the Company’s results. However, non-GAAP financial measures should not be considered substitute for, nor superior to, financial results and measures determined or calculated in accordance with GAAP.

The following is a reconciliation of net income, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:

                                                   
                                         
Three Months Ended Six Months Ended
  6/30/2012   6/30/2011   6/30/2012   6/30/2011
 
Net income, as reported $ 133,368 $ 111,180 $ 241,530 $ 199,199
Write-off of unamortized deferred financing cost
from debt refinancing (net of $214 tax benefit)   -   -   -   700
Net income, as adjusted $ 133,368 $ 111,180 $ 241,530 $ 199,899
                                                   
 
 

The following is a reconciliation of diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to diluted earnings per share adjusted for certain items:

                                                   
 
Three Months Ended   Six Months Ended
  6/30/2012   6/30/2011     6/30/2012   6/30/2011
 
Diluted earnings per share, as reported $ 1.10 $ 0.88 $ 1.98 $ 1.57
Write-off of unamortized deferred financing cost
from debt refinancing   -   -     -   0.01
Diluted earnings per share, as adjusted $ 1.10 $ 0.88   $ 1.98 $ 1.58
 

The following is a reconciliation of total long-term debt to net debt:

              6/30/2012                 12/31/2011  
 
Total long-term debt (current and long-term portion) $ 555,814 $ 203,621
Less: Cash and cash equivalents   286,166   258,775  
Net debt $ 269,648 $ (55,154 )
 

Contacts

Herbalife Ltd.
Media Contact:
Barbara Henderson
SVP, Worldwide Corp. Comm.
213-745-0517
or
Investor Contact:
Amy Greene
VP, Investor Relations
213-745-0474

Release Summary

Herbalife Ltd. (NYSE: HLF) today reported second quarter record net sales of $1.0 billion, a 17 percent increase, driven by a 23 percent increase in volume points compared to the prior year period.

Sharing

Contacts

Herbalife Ltd.
Media Contact:
Barbara Henderson
SVP, Worldwide Corp. Comm.
213-745-0517
or
Investor Contact:
Amy Greene
VP, Investor Relations
213-745-0474